Inspire wins FDA approval for obstructive sleep apnea neurostimulator therapy

Inspire wins FDA approval for obstructive sleep apnea neurostimulator therapy

Source: 
Medtech Dive
snippet: 

Inspire Medical Systems received Food and Drug Administration approval for its Inspire V obstructive sleep apnea (OSA) neurostimulator therapy, the company said Friday.